The landscape of blood sugar treatment is evolving with the arrival of skin-applied GLP-1 therapy. These novel patches offer a likely simpler alternative to injections for individuals dealing with diabetes 2. Such a system deliver glucagon-like peptide-1 directly through the epidermis, circumvent